Keyphrases
1p/19q Codeletion
100%
After Surgery
11%
Anaplastic Astrocytoma
55%
Anaplastic Glioma
100%
Anaplastic Oligoastrocytoma
100%
Anaplastic Oligodendroglioma
100%
Clinical Outcomes
11%
Heterogeneous Groups
11%
High-grade Brain Tumor
11%
Histological Subtypes
11%
Histology
100%
Historical Controls
11%
Institutional Data
11%
Lomustine
11%
Molecular Subtypes
22%
Multivariate Analysis
11%
Overall Survival
66%
Performance Status
11%
Postoperative Treatment
11%
Procarbazine
11%
Progression-free Survival
33%
Promising Treatment
11%
Radiation Therapy
100%
Retrospective Review
11%
Single Institution
11%
Supratentorial
11%
Temozolomide
100%
Total Dose
11%
Medicine and Dentistry
Ganglioglioma
100%
Glioblastoma
55%
Intracranial Tumor
11%
Lomustine
11%
Multivariate Analysis
11%
Oligoastrocytoma
100%
Oligodendroglioma
100%
Overall Survival
66%
Postoperative Care
11%
Procarbazine
11%
Progression Free Survival
33%
Radiation Therapy
100%
Temozolomide
100%
Vincristine
11%
Neuroscience
Astrocytoma
55%
Intracranial Tumor
11%
Lomustine
11%
Oligodendroglioma
100%
Procarbazine
11%
Radiation Therapy
100%
Temozolomide
100%
Vincristine
11%